Medtronic in collaboration with UCSF researchers, led by Maria Shcherbakova, has developed adaptive deep brain stimulation technology that automatically adjusts brain implants in real time to better control symptoms of Parkinson’s disease. This innovation represents a significant improvement over traditional constant stimulation, potentially enhancing patient outcomes and quality of life by dynamically responding to fluctuating neurological signals.